British Chemistry Start-Up Glycoform Gets $1.7 Million Second Round

Glycoform Ltd., a biotech firm that is using glycosylation chemistry technology in drug delivery and in the development of protein therapeutics, said that it has raised GBP960,000 ($1.7 million) in its second round of venture financing.